Sep 2026· International Journal of Molecular Sciences· Vol 27· 0 citations· 49 references
Medicine
TL;DR
Results further underscore baseline tissue state as a major source of variation in small, heterogeneous bulk-tissue cohorts and provide a framework for future cell-resolved studies of tissue variation and disease susceptibility.
Abstract
Population-associated molecular variation in breast tissue may contribute to differences in tissue biology and disease susceptibility. Still, the extent to which such variation is shaped by underlying tissue state remains unclear. We performed a pilot RNA-seq and lipidomic analysis of histologically normal breast tissue from African American (AA) and Caucasian White (CW) individuals. Unsupervised transcriptomic analysis identified two baseline tissue states, G1 and G2, representing the dominant axis of molecular variation and associated with epithelial-enriched and vascular-enriched tissue contexts, respectively. Across the full cohort, AA and CW samples showed minimal transcriptomic differences. However, within G1, 191 genes were differentially expressed between AA and CW samples, with coordinated enrichment of extracellular matrix organization and proliferative/cytoskeletal processes in AA samples; these patterns were consistent across enrichment methods and sensitivity analyses. No comparable population-associated transcriptional signal was detected in G2. Lipidomic profiles showed limited separation and no robust population-associated differences after correction for multiple testing. Together, these pilot findings suggest that population-associated molecular variation in histologically normal breast tissue may be state-dependent, becoming detectable within a specific baseline transcriptional context rather than uniformly across the cohort. These results further underscore baseline tissue state as a major source of variation in small, heterogeneous bulk-tissue cohorts and provide a framework for future cell-resolved studies of tissue variation and disease susceptibility.
A unified, multi-cohort transcriptional landscape of breast cancer that organizes canonical subtypes along continuous biological axes and reveals spatially structured regions of therapeutic sensitivity and resistance is presented.
Sonali Arora, Ramya Suresh, N. Holland et al.· bioRxiv· 0 citations
Results demonstrate that CIS exhibits significant intra-patient heterogeneity not captured by single-site profiling, and support multi-region sampling, which could help improve risk stratification, biomarker development, and prediction of response to intravesical therapies.
Tyler D. Myers, A. Salmasi, M. Meagher et al.· bioRxiv· 0 citations
Background Chromosome 4 open reading frame 50 (C4orf50) is a poorly characterized gene whose expression pattern and clinical relevance in breast cancer remain unclear. We aimed to evaluate the expression, prognostic association, immune microenvironment correlates, and transcriptional features associated with C4orf50 in...
Si-Hang Lin, Li-Xia Liu, Jia-Yu Guan et al.· Translational Cancer Researc...· 0 citations
MZT1 is a proliferation-associated marker that integrates clinical risk, transcriptional programs, cellular heterogeneity, and predictive modeling in LUAD, providing a potential framework for biomarker development and risk stratification.
Dahlak Daniel Solomon, Hui-Ru Lin, Yung-Kuo Lee et al.· Cancer Genomics & Proteomics· 0 citations
Locoregional recurrence (LRR) poses a persistent clinical challenge in breast cancer, with emerging evidence implicating the tumor-associated adipose tissue in modulating recurrence risk. This study investigates shared transcriptional programs between adipose tissue and breast tumors and examines their association with...
Marlous Arjaans, B. van der Vegt, Renske Linstra et al.· Functional & Integrative Gen...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.